Prognostic assessment after surgical resection for non-small cell lung cancer: experiences in 2083 patients.
about
Role of HER2 in NSCLCPrognostic value of ERCC1 mRNA expression in non-small cell lung cancer, breast cancer, and gastric cancer in patients from Southern ChinaPrevalence, Prognostic Implications, and Survival Modulators of Incompletely Resected Non-Small Cell Lung Cancer in the U.S. National Cancer Data Base.Prognostic factors in resected lung carcinomas.Clinicopathologic features and prognostic implications of NOK/STYK1 protein expression in non-small cell lung cancer.Overexpression of both platelet-derived growth factor-BB and vascular endothelial growth factor-C and its association with lymphangiogenesis in primary human non-small cell lung cancerThe impact of a novel lung gross dissection protocol on intrapulmonary lymph node retrieval from lung cancer resection specimens.Gene expression-based prognostic signatures in lung cancer: ready for clinical use?Long-term survival outcomes by smoking status in surgical and nonsurgical patients with non-small cell lung cancer: comparing never smokers and current smokers.Improving lung cancer outcomes by improving the quality of surgical care.Prognostic Factors for Survival of Stage IB Upper Lobe Non-small Cell Lung Cancer Patients: A Retrospective Study in Shanghai, China.Predicting recurrence using the clinical factors of patients with non-small cell lung cancer after curative resection.Clinical value of circulating endothelial cells and of soluble CD146 levels in patients undergoing surgery for non-small cell lung cancer.Genetic characterization drives personalized therapy for early-stage non-small-cell lung cancer (NSCLC) patients and survivors with metachronous second primary tumor (MST): A case report.Clinical outcomes in non-small-cell lung cancer in relation to expression of predictive and prognostic biomarkers.Evolution in the Surgical Care of Patients With Non-Small Cell Lung Cancer in the Mid-South Quality of Surgical Resection Cohort.Strategic targeting of the PI3K-NFκB axis in cisplatin-resistant NSCLC.Concentration- and time-dependent effects of enoxaparin on human adenocarcinomic epithelial cell line A549 proliferation in vitro.The burdens of lung cancer involved multiple primary cancers and its occurring patterns-SEER Analysis between 1973 and 2006.Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non-Small Cell Lung CancerToxicological effects of NCKU-21, a phenanthrene derivative, on cell growth and migration of A549 and CL1-5 human lung adenocarcinoma cells.Improving post-resection risk stratification in non-small cell lung cancer: 'wit, whither wander you?'Expression levels of some antioxidant and epidermal growth factor receptor genes in patients with early-stage non-small cell lung cancer.Morphological analysis of circulating tumour cells in patients undergoing surgery for non-small cell lung carcinoma using the isolation by size of epithelial tumour cell (ISET) method.Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method.CXCL14 and NOS1 expression in specimens from patients with stage I-IIIA nonsmall cell lung cancer after curative resection.[The International Association for the Study of Lung Cancer Staging Project. Prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer].ALK-gene rearrangement: a comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinoma.Positive Surgical Margins in the 10 Most Common Solid Cancers.[Prognostic value of lymphangiogenesis and lymphatic vessel invasion in non-small cell lung cancer].[The clinical significance of β-arrestin 2 expression in the serum of non-small cell lung cancer patients].
P2860
Q26781683-82A678D4-E729-419B-8E1D-5840463E5A50Q26865990-A1496462-D40F-4E1A-A14E-1BF9C6A33135Q31036733-358A4A88-3288-4724-8A90-37D0165690D2Q33697964-CBB98864-D4E4-4A22-9DC4-1BB486F10C52Q33732190-C9C456AB-A2FC-4A71-B0DE-7F77350EAA03Q33859145-DBC1C965-A9E1-4B3D-BD1F-611298484532Q33905550-3CF1D338-F568-4221-BFA6-0EAB5E66557EQ33988433-87B5455C-D668-4BBD-A2AB-2396A44C104AQ34130681-1E666493-16AD-491D-87A3-2D0E9EEBFBA7Q35996052-46EED28D-8FC1-4104-94FC-0367FA353B0BQ36551088-47BB557C-F7FF-41BD-8C5D-408D16EAEF2BQ37364511-DBE6D979-E572-48EE-93FC-574770EF8715Q37632126-B2B92C3D-B27F-484C-B066-91A2FFB56613Q37696841-23AF026C-D650-4E31-AE54-56C6964EF874Q37750786-8247B10A-F7AE-4883-8B06-AC35C86575F8Q38690568-6CF34928-3160-4806-B396-97062A7F8231Q38975225-755189CF-7939-4033-94A6-45755822B2C8Q39476635-353F2257-B6CC-42B7-98F0-7E383A7399A6Q40108556-B400F1EF-937E-4131-BD80-2F4E7C1F3353Q40717001-BCECBDCD-3BF2-4594-AA04-FD7DCCCBAA9DQ42288158-A2D51ADA-B2D8-4733-8C60-2B7F9E62CECFQ42384614-DB36CEAC-B953-4EDD-96CC-907A902C7E2DQ42672586-48D3120F-9E42-4A14-856D-4134691CD5CCQ47397525-D8346C1B-5CD5-4BF3-9F6E-CCE72D955042Q47402499-E93E43CF-9BC8-401A-8A5B-04BA1693E914Q51735301-7DD4D610-E7D8-409A-ABC4-098999928F61Q53462930-CD276304-2959-4F47-9028-E5D9C6A5362BQ54501643-DB0377E4-0C10-4040-92BF-82B8ADA381FAQ55174606-F20F6B70-215F-4EC2-B69D-F92262E35157Q55464272-21A9857D-0936-48C0-9A8E-8B518C909A66Q55464399-198163D5-E6F8-47F7-9CFE-EA754BBA29A3
P2860
Prognostic assessment after surgical resection for non-small cell lung cancer: experiences in 2083 patients.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Prognostic assessment after su ...... experiences in 2083 patients.
@ast
Prognostic assessment after su ...... experiences in 2083 patients.
@en
type
label
Prognostic assessment after su ...... experiences in 2083 patients.
@ast
Prognostic assessment after su ...... experiences in 2083 patients.
@en
prefLabel
Prognostic assessment after su ...... experiences in 2083 patients.
@ast
Prognostic assessment after su ...... experiences in 2083 patients.
@en
P2093
P1433
P1476
Prognostic assessment after su ...... experiences in 2083 patients.
@en
P2093
Hans Hoffmann
Heinrich Bülzebruck
Hendrik Dienemann
Joachim Pfannschmidt
Thomas Muley
P304
P356
10.1016/J.LUNGCAN.2006.10.017
P577
2006-11-22T00:00:00Z